Medical devices, healthcare technology and the business of care
510(k) clearance · K260640

Kinetic Software Library

Monebo Technologies, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONK260640

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on October 23, 2026 for the Kinetic Software Library, submitted by Monebo Technologies, Inc. under K260640. The device is an electrocardiograph software library (21 CFR 870.2340, Class II, product code DPS) intended for integration into a client's ECG device through an API; the summary states it has no user interface and produces no physical report. The listed predicate is Monebo's Automated ECG Analysis and Interpretation Software Library (K062282).

The summary describes signal processing and analysis functions including QRS detection, ectopic beat detection, QRS feature extraction, heart rate measurement and rhythm analysis, and states the library is not intended for life-supporting systems or ECG monitoring and alarm devices. The public record does not include the decision statement text, so the basis for the equivalence finding is not established here; the summary's comparison tables and the applicant's conclusion are not independent FDA findings.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260640
Regulatory pathway
510(k) premarket notification
Product code
DPS
Decision code
SESE
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Electrocardiograph.

Product code
DPS
FDA device class
2

FDA decision timeline

  1. K260640 received

    Application receipt date recorded by FDA.

  2. K260640 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DPS

Product / regulatory recordCompanyPathwayDecision dateSource
HeartSciences, Inc.510(k) clearanceOct 5, 2026FDA
QT Medical, Inc.510(k) clearanceSep 29, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Monebo Technologies, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Austin, TX

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records